Request Sample Inquiry
Non Alcoholic Steatohepatitis (nash) Market

Non Alcoholic Steatohepatitis (NASH) Market

Non Alcoholic Steatohepatitis (NASH) Market - Global Industry Assessment & Forecast

Number Of Pages # Pages:

169

Base Year:

2022

Date

Jan - 2022

Format:

PDF XLS PPT

Report Code:

VMR-1253

Segments Covered
  • By Drug Type By Drug Type Vitamin E & Pioglitazone, Ocaliva, Elafibranor, Selonsertib, Cencicriviroc, Others
  • By Sales Channel By Sales Channel Hospital Pharmacy, Online Provider, Retail Pharmacy
  • By Region By Region North America, Latin America, Europe, Asia Pacific, Middle East & Africa
Snapshot
Base YearBase Year: 2022
Forecast YearsForecast Years: 2023 - 2030
Historical YearsHistorical Years: 2017 - 2021
Revenue 2022Revenue 2022: USD 2511.97 Million
Revenue 2030Revenue 2030: USD 108428.91 Million
Revenue CAGRRevenue CAGR (2023 - 2030): 60.10%
Fastest Growing Region Fastest Growing Region (2023 - 2030) Asia Pacific
Largest Region Largest Region (2022): North America
Customization Offered
  • Cross-segment Market Size and Analysis for Mentioned Segments Cross-segment Market Size and Analysis for Mentioned Segments
  • Additional Company Profiles (Upto 5 With No Cost) Additional Company Profiles (Upto 5 With No Cost)
  • Additional Countries (Apart From Mentioned Countries) Additional Countries (Apart From Mentioned Countries)
  • Country/Region-specific Report Country/Region-specific Report
  • Go To Market Strategy Go To Market Strategy
  • Region Specific Market Dynamics Region Specific Market Dynamics
  • Region Level Market Share Region Level Market Share
  • Import Export Analysis Import Export Analysis
  • Production Analysis Production Analysis
  • Other Others Request Customization Speak To Analyst

Non Alcoholic Steatohepatitis (NASH) Market Segment Analysis

  • Non Alcoholic Steatohepatitis (NASH) Drug Type Outlook (Revenue, USD Million, 2018 - 2030)
    • Vitamin E & Pioglitazone
    • Ocaliva
    • Elafibranor
    • Selonsertib
    • Cencicriviroc
    • Others
  • Non Alcoholic Steatohepatitis (NASH) Sales Channel Outlook (Revenue, USD Million, 2018 - 2030)
    • Hospital Pharmacy
    • Online Provider
    • Retail Pharmacy
  • Regional Outlook (Revenue, USD Billion/Million, 2018 - 2030)
    • North America
      • North America Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
        • Vitamin E & Pioglitazone
        • Ocaliva
        • Elafibranor
        • Selonsertib
        • Cencicriviroc
        • Others
      • North America Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
        • Hospital Pharmacy
        • Online Provider
        • Retail Pharmacy
      • U.S.
        • U.S. Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • U.S. Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Canada
        • Canada Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Canada Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Mexico
        • Mexico Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Mexico Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
    • Europe
      • Europe Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
        • Vitamin E & Pioglitazone
        • Ocaliva
        • Elafibranor
        • Selonsertib
        • Cencicriviroc
        • Others
      • Europe Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
        • Hospital Pharmacy
        • Online Provider
        • Retail Pharmacy
      • U. K.
        • U.K. Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • U.K. Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • France
        • France Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • France Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Germany
        • Germany Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Germany Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Italy
        • Italy Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Italy Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Spain
        • Spain Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Spain Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Rest of Europe
        • Rest of Europe Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Rest of Europe Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
    • Asia Pacific
      • Asia Pacific Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
        • Vitamin E & Pioglitazone
        • Ocaliva
        • Elafibranor
        • Selonsertib
        • Cencicriviroc
        • Others
      • Asia Pacific Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
        • Hospital Pharmacy
        • Online Provider
        • Retail Pharmacy
      • China
        • China Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • China Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Japan
        • Japan Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Japan Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Germany
        • Germany Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Germany Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • India
        • India Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • India Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • South Korea
        • South Korea Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • South Korea Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • South East Asia
        • South East Asia Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • South East Asia Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Rest of Asia Pacific
        • Rest of Asia Pacific Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Rest of Asia Pacific Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
    • Latin America
      • Latin America Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
        • Vitamin E & Pioglitazone
        • Ocaliva
        • Elafibranor
        • Selonsertib
        • Cencicriviroc
        • Others
      • Latin America Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
        • Hospital Pharmacy
        • Online Provider
        • Retail Pharmacy
      • Brazil
        • Brazil Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Brazil Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Argentina
        • Argentina Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Argentina Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Rest of Latin America
        • Rest of Latin America Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Rest of Latin America Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
    • Middle East & Africa
      • Middle East & Africa Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
        • Vitamin E & Pioglitazone
        • Ocaliva
        • Elafibranor
        • Selonsertib
        • Cencicriviroc
        • Others
      • Middle East & Africa Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
        • Hospital Pharmacy
        • Online Provider
        • Retail Pharmacy
      • GCC Countries
        • GCC Countries Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • GCC Countries Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • South Africa
        • South Africa Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • South Africa Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
      • Rest of Middle East & Africa
        • Rest of Middle East & Africa Non Alcoholic Steatohepatitis (NASH) Market, by Drug Type
          • Vitamin E & Pioglitazone
          • Ocaliva
          • Elafibranor
          • Selonsertib
          • Cencicriviroc
          • Others
        • Rest of Middle East & Africa Non Alcoholic Steatohepatitis (NASH) Market, by Sales Channel
          • Hospital Pharmacy
          • Online Provider
          • Retail Pharmacy
FAQ
Frequently Asked Question
  • The global Non Alcoholic Steatohepatitis (NASH) valued at USD 2511.97 Million in 2022 and is expected to reach USD 108428.91 Million in 2030 growing at a CAGR of 60.10%.

  • The prominent players in the market are Genfit, Allergan plc (Tobira Therapeutics, Inc.), Bristol-Myers Squibb Company, Conatus Pharmaceuticals, Galectin Therapeutics, Inc..

  • The market is project to grow at a CAGR of 60.10% between 2023 and 2030.

  • The driving factors of the Non Alcoholic Steatohepatitis (NASH) include

    • High Prevalence of Hypertension

  • North America was the leading regional segment of the Non Alcoholic Steatohepatitis (NASH) in 2022.